| User's Publication |
|
21077
Ishibashi Y, Mochizuki S, Horiuchi K, Tsujimoto H, Kouzu K, Kishi Y, Okada Y, Ueno H.
Periostin derived from cancer-associated fibroblasts promotes esophageal squamous cell carcinoma progression via ADAM17 activation.
Biochim Biophys Acta Mol Basis Dis
2023
1869(5):166669
PubMed ID: 36813090
DOI: 10.1016/j.bbadis.2023.166669
|
|
21175
Zhang X, Wang Y, Zhang X, Shen Y, Yang K, Ma Q, Qiao Y, Shi J, Wang Y, Xu L, Yang B, Ge G, Hu L, Kong X, Yang C, Chen Y, Ding J, Meng L.
Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors.
Signal Transduct Target Ther
2023
8(1):153
PubMed ID: 37041169
DOI: 10.1038/s41392-023-01359-x
|
|
21406
Nguyen Vu TH, Kikuchi O, Ohashi S, Saito T, Ida T, Nakai Y, Cao Y, Yamamoto Y, Kondo Y, Mitani Y, Kataoka S, Kondo T, Katada C, Yamada A, Matsubara J, Muto M.
Combination therapy with WEE1 inhibition and trifluridine/tipiracil against esophageal squamous cell carcinoma.
Cancer Sci
2023
PubMed ID: 37724648
DOI: 10.1111/cas.15966
|
|
20614
Tsuchihashi K, Hirata Y, Yamasaki J, Suina K, Tanoue K, Yae T, Masuda K, Baba E, Akashi K, Kitagawa Y, Saya H, Nagano O.
Presence of spontaneous epithelial-mesenchymal plasticity in esophageal cancer.
Biochem Biophys Rep
2022
30:101246
PubMed ID: 35330672
DOI: 10.1016/j.bbrep.2022.101246
|
|
20666
Li Z, Zou L, Xiao ZX, Yang J.
Transcriptome‑based drug repositioning identifies TPCA‑1 as a potential selective inhibitor of esophagus squamous carcinoma cell viability.
Int J Mol Med
2022
49(6)
PubMed ID: 35417037
DOI: 10.3892/ijmm.2022.5131
|
|
20714
Zhai Y, Shan C, Zhang H, Kong P, Zhang L, Wang Y, Hu X, Cheng X.
FAT1 downregulation enhances stemness and cisplatin resistance in esophageal squamous cell carcinoma.
Mol Cell Biochem
2022
PubMed ID: 35606602
DOI: 10.1007/s11010-022-04475-4
|
|
13104
Yoshida T, Yokobori T, Saito H, Kuriyama K, Kumakura Y, Honjo H, Hara K, Sakai M, Miyazaki T, Obinata H, Erkhem-Ochir B, Gombodorj N, Sohda M, Saeki H, Kuwano H, Shirabe K.
CD36 Expression Is Associated with Cancer Aggressiveness and Energy Source in Esophageal Squamous Cell Carcinoma.
Ann Surg Oncol
2021
PubMed ID: 32529269
DOI: 10.1245/s10434-020-08711-3
|
|
16116
Kobayashi T, Makino T, Yamashita K, Saito T, Tanaka K, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Morii E, Eguchi H, Doki Y.
APR-246 induces apoptosis and enhances chemo-sensitivity via activation of ROS and TAp73-Noxa signal in oesophageal squamous cell cancer with TP53 missense mutation
Br J Cancer
2021
125(11):1523-1532
PubMed ID: 34599296
DOI: 10.1038/s41416-021-01561-0
|
|
16743
Ogo A, Miyake S, Kubota H, Higashida M, Matsumoto H, Teramoto F, Hirai T, Ueno T.
The Mechanism of the Synergistic Anticancer Effect of CDDP and EPA in the TE1 Cell Line
Anticancer Res
2021
41(4):1771-1778
PubMed ID: 33813381
DOI: 10.21873/anticanres.14942
|
|
13092
Feng Y, Yan S, Huang Y, Huang Q, Wang F, Lei Y.
High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma.
BMC Cancer
2020
PubMed ID: 32600359
DOI: 10.1186/s12885-020-07068-w
|
|
13113
Kunishige T, Migita K, Matsumoto S, Wakatsuki K, Nakade H, Miyao S, Kuniyasu H, Sho M.
Ring box protein-1 is associated with a poor prognosis and tumor progression in esophageal cancer.
Oncol Lett
2020
PubMed ID: 32782608
DOI: 10.3892/ol.2020.11840
|
|
13206
Kubota H, Hirai T, Yamauchi A, Ogo A, Matsumoto H, Ueno T.
Inhibitory Effect of Eicosapentaenoic Acid on the Migration of the Esophageal Squamous Cell Carcinoma Cell Line TE-1.
Anticancer Res
2020
PubMed ID: 32878792
DOI: 10.21873/anticanres.14507
|
|
13600
Sano H, Futamura M, Gaowa S, Kamino H, Nakamura Y, Yamaguchi K, Tanaka Y, Yasufuku I, Nakakami A, Arakawa H, Yoshida K.
p53/Mieap-regulated mitochondrial quality control plays an important role as a tumor suppressor in gastric and esophageal cancers
Biochem Biophys Res Commun
2020
529(3):582-589.
PubMed ID: 32736677
DOI: 10.1016/j.bbrc.2020.05.168
|
|
14366
Ito S, Masuda T, Noda M, Hu Q, Shimizu D, Kuroda Y, Eguchi H, Tobo T, Utsunomiya T, Mimori K.
Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer
Oncology
2020
98(7):501-511
PubMed ID: 32380498
DOI: 10.1159/000506075
|
|
14800
Ohashi S, Kikuchi O, Nakai Y, Ida T, Saito T, Kondo Y, Yamamoto Y, Mitani Y, Nguyen Vu TH, Fukuyama K, Tsukihara H, Suzuki N, Muto M.
Synthetic Lethality with Trifluridine/Tipiracil and Checkpoint Kinase 1 Inhibitor for Esophageal Squamous Cell Carcinoma
Mol Cancer Ther
2020
19(6):1363-1372
PubMed ID: 32371587
DOI: 10.1158/1535-7163.MCT-19-0918
|
|
18204
Ooizumi Y, Katoh H, Yokota M, Watanabe M, Yamashita K.
Epigenetic silencing of HOPX is critically involved in aggressive phenotypes and patient prognosis in papillary thyroid cancer
Oncotarget
2019
10(57):5906-5918
PubMed ID: 31666923
DOI: 10.18632/oncotarget.27187
|
|
11491
Shafaee A, Pirayesh Islamian J, Zarei D, Mohammadi M, Nejati-Koshki K, Farajollahi A, Aghamiri SMR, Rahmati Yamchi M, Baradaran B, Asghari Jafarabadi M.
Induction of Apoptosis by a Combination of 2-Deoxyglucose and Metformin in Esophageal Squamous Cell Carcinoma by Targeting Cancer Cell Metabolism.
Iran J Med Sci
2019
PubMed ID: 30936596
|
|
11455
Miyake S, Ogo A, Kubota H, Teramoto F, Hirai T.
β-Hydroxy-β-methylbutyrate Suppresses NF-ĸB Activation and IL-6 Production in TE-1 Cancer Cells.
In Vivo
2019
PubMed ID: 30804112
DOI: 10.21873/invivo.11481
|
|
11526
Liu J, Min L, Zhu S, Guo Q, Li H, Zhang Z, Zhao Y, Xu C, Zhang S.
Cyclin-Dependent Kinase Inhibitor 3 Promoted Cell Proliferation by Driving Cell Cycle from G1 to S Phase in Esophageal Squamous Cell Carcinoma.
J Cancer
2019
PubMed ID: 31205550
DOI: 10.7150/jca.27053
|
|
11699
Kiyozumi Y, Baba Y, Okadome K, Yagi T, Ogata Y, Eto K, Hiyoshi Y, Ishimoto T, Iwatsuki M, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Baba H.
Indoleamine 2, 3-dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer.
Cancer Sci
2019
110(6):1863-1871
PubMed ID: 31012515
DOI: 10.1111/cas.14028
|
|
12594
Kalikawe R, Baba Y, Nomoto D, Okadome K, Miyake K, Eto K, Hiyoshi Y, Nagai Y, Iwatsuki M, Ishimoto T, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Baba H.
Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer
Cancer Sci
2019
110(12):3727-3737
PubMed ID: 31599475
DOI: 10.1111/cas.14214
|
|
12595
Sawayama H, Ogata Y, Ishimoto T, Mima K, Hiyoshi Y, Iwatsuki M, Baba Y, Miyamoto Y, Yoshida N, Baba H.
Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer
Cancer Sci
2019
110(5):1705-1714
PubMed ID: 30861255
DOI: 10.1111/cas.13995
|
|
12596
Son SW, Chau GC, Kim ST, Um SH.
Vacuolar H +-ATPase Subunit V0C Regulates Aerobic Glycolysis of Esophageal Cancer Cells via PKM2 Signaling
Cells
2019
8(10):1137
PubMed ID: 31554233
DOI: 10.3390/cells8101137
|
|
10798
Shinno N, Kimura H, Sada R, Takiguchi S, Mori M, Fumoto K, Doki Y, Kikuchi A.
Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug.
Oncogene
2018
37(26):3471-3484
PubMed ID: 29563607
DOI: 10.1038/s41388-018-0179-2
|
|
4355
Furukawa H, Makino T, Yamasaki M, Tanaka K, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y.
PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.
Cancer Sci.
2018
109(2):412-421
PubMed ID: 29168598
DOI: 10.1111/cas.13454
|
|
4356
Ishibashi O, Akagi I, Ogawa Y, Inui T.
MiR-141-3p is upregulated in esophageal squamous cell carcinoma and targets pleckstrin homology domain leucine-rich repeat protein phosphatase-2, a negative regulator of the PI3K/AKT pathway.
Biochem Biophys Res Commun.
2018
501(2):507-513
PubMed ID: 29738771
DOI: 10.1016/j.bbrc.2018.05.025
|
|
4357
Kim MJ, Choi SK, Hong SH, Eun JW, Nam SW, Han JW, You JS.
Oncogenic IL7R is downregulated by histone deacetylase inhibitor in esophageal squamous cell carcinoma via modulation of acetylated FOXO1.
Int. J. Oncol.
2018
53(1):395-403
PubMed ID: 29749437
DOI: 10.3892/ijo.2018.4392
|
|
4504
Piao L, Yang Z, Jin J, Ni W, Qi W, Xuan Y.
B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma.
Hum. Pathol.
2018
80:152-162
PubMed ID: 29885401
DOI: 10.1016/j.humpath.2018.05.021
|
|
4505
Yang Z, Ni W, Cui C, Qi W, Piao L, Xuan Y.
Identification of LETM1 as a marker of cancer stem-like cells and predictor of poor prognosis in esophageal squamous cell carcinoma.
Hum. Pathol.
2018
81:148-156
PubMed ID: 30031102
DOI: 10.1016/j.humpath.2018.07.001
|
|
9448
Chihiro Kajiwara, Katsumi Fumoto, Hirokazu Kimura, Satoshi Nojima, Keita Asano, Kazuki Odagiri, Makoto Yamasaki, Hayato Hikita, Tetsuo Takehara, Yuichiro Doki, Eiichi Morii, Akira Kikuchii
p63-Dependent Dickkopf3 Expression Promotes Esophageal Cancer Cell Proliferation via CKAP4
Cancer Res
2018
78(21):6107-6120
PubMed ID: 30181180
DOI: 10.1158/0008-5472.CAN-18-1749
|
|
9998
Hijiya N, Shibata T, Daa T, Hamanaka R, Uchida T, Matsuura K, Tsukamoto Y, Nakada C, Iha H, Inomata M, Moriyama M.
Overexpression of cannabinoid receptor 1 in esophageal squamous cell carcinoma is correlated with metastasis to lymph nodes and distant organs, and poor prognosis.
Pathol. Int.
2017
67:83-90
PubMed ID: 27976824
DOI: 10.1111/pin.12495
|
|
10004
Iwaya T, Sawada G, Amano S, Kume K, Ito C, Endo F, Konosu M, Shioi Y, Akiyama Y, Takahara T, Otsuka K, Nitta H, Koeda K, Mizuno M, Nishizuka S, Sasaki A, Mimori K.
Downregulation of ST6GALNAC1 is associated with esophageal squamous cell carcinoma development.
Int. J. Oncol.
2017
50:441-447
PubMed ID: 28035351
DOI: 10.3892/ijo.2016.3817
|
|
10049
Wong M, Funasaka K, Obayashi T, Miyahara R, Hirooka Y, Hamaguchi M, Goto H, Senga T.
AMPD3 is associated with the malignant characteristics of gastrointestinal stromal tumors.
Oncol Lett
2017
13:1281-1287
PubMed ID: 28454247
DOI: 10.3892/ol.2016.5532
|
|
10116
Akagi I, Ishibashi O.
RNA-Seq analysis of human cell lines established from normal and neoplastic esophageal squamous epithelium.
Genom Data
2017
12:4-6
PubMed ID: 28224081
DOI: 10.1016/j.gdata.2017.02.002
|
|
10141
Sugase T, Takahashi T, Serada S, Nakatsuka R, Fujimoto M, Ohkawara T, Hara H, Nishigaki T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Kishimoto T, Mori M, Doki Y, Naka T.
Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.
Int. J. Cancer
2017
140:2608-2621
PubMed ID: 28233302
DOI: 10.1002/ijc.30666
|
|
10304
Sato H, Wu Y, Kato Y, Liu Q, Hirai H, Yoshizawa T, Morohashi S, Watanabe J, Kijima H.
DEC2 expression antagonizes cisplatin‑induced apoptosis in human esophageal squamous cell carcinoma.
Mol Med Rep
2017
16:43-48
PubMed ID: 28498447
DOI: 10.3892/mmr.2017.6571
|
|
10353
Kawaguchi T, Komatsu S, Ichikawa D, Hirajima S, Nishimura Y, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E.
Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma.
Tumour Biol.
2017
39:1010428317700409
PubMed ID: 28618928
DOI: 10.1177/1010428317700409
|
|
10365
Yamamoto M, Yamasaki M, Tsukao Y, Tanaka K, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y.
Poly (ADP-ribose) polymerase-1 inhibition decreases proliferation through G2/M arrest in esophageal squamous cell carcinoma.
Oncol Lett
2017
14:1581-1587
PubMed ID: 28789382
DOI: 10.3892/ol.2017.6334
|
|
10449
Yoshioka M, Ohashi S, Ida T, Nakai Y, Kikuchi O, Amanuma Y, Matsubara J, Yamada A, Miyamoto S, Natsuizaka M, Nakagawa H, Chiba T, Seno H, Muto M.
Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells.
J. Exp. Clin. Cancer Res.
2017
36:101
PubMed ID: 28764725
DOI: 10.1186/s13046-017-0572-7
|
|
10977
Role of HDM2 Gene in Radio-Sensitivity of Esophageal Cancer Cell Lines to Irradiation
Int J Cancer Manag
2017
10:e8950
DOI: 10.5812/ijcm.8950
|
|
14626
Kumakura Y, Rokudai S, Iijima M, Altan B, Yoshida T, Bao H, Yokobori T, Sakai M, Sohda M, Miyazaki T, Nishiyama M, Kuwano H.
Elevated expression of ΔNp63 in advanced esophageal squamous cell carcinoma
Cancer Sci
2017
108(11):2149-2155
PubMed ID: 28892579
DOI: 10.1111/cas.13394
|
|
14646
Tanabe K, Shinsato Y, Furukawa T, Kita Y, Hatanaka K, Minami K, Kawahara K, Yamamoto M, Baba K, Mori S, Uchikado Y, Maemura K, Tanimoto A, Natsugoe S.
Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma
Oncotarget
2017
8(4):6353-6363
PubMed ID: 28031525
DOI: 10.18632/oncotarget.14087
|
|
14654
Hadisaputri YE, Miyazaki T, Yokobori T, Sohda M, Sakai M, Ozawa D, Hara K, Honjo H, Kumakura Y, Kuwano H.
TNFAIP3 overexpression is an independent factor for poor survival in esophageal squamous cell carcinoma
Int J Oncol
2017
50(3):1002-1010
PubMed ID: 28197630
DOI: 10.3892/ijo.2017.3869
|
|
14743
Osako Y, Seki N, Koshizuka K, Okato A, Idichi T, Arai T, Omoto I, Sasaki K, Uchikado Y, Kita Y, Kurahara H, Maemura K, Natsugoe S.
Regulation of SPOCK1 by dual strands of pre-miR-150 inhibit cancer cell migration and invasion in esophageal squamous cell carcinoma
J Hum Genet
2017
62(11):935-944
PubMed ID: 28659612
DOI: 10.1038/jhg.2017.69
|
|
9724
Hara H, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Nakatsuka R, Harada E, Nishigaki T, Takahashi Y, Nojima S, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Miyata H, Nakajima K, Takiguchi S, Morii E, Mori M, Doki Y, Naka T.
Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma.
Br. J. Cancer
2016
115:66-75
PubMed ID: 27310703
DOI: 10.1038/bjc.2016.183
|
|
9883
Schlierf A, Altmann E, Quancard J, Jefferson AB, Assenberg R, Renatus M, Jones M, Hassiepen U, Schaefer M, Kiffe M, Weiss A, Wiesmann C, Sedrani R, Eder J, Martoglio B.
Targeted inhibition of the COP9 signalosome for treatment of cancer.
Nat Commun
2016
7:13166
PubMed ID: 27774986
DOI: 10.1038/ncomms13166
|
|
10881
RGD conjugated, Cy5.5 labeled polyamidoamine dendrimers for targeted near-infrared fluorescence imaging of esophageal squamous cell carcinoma
RSC Adv.
2016
6, 74560-74566
DOI: 10.1039/C6RA12927G
|
|
12618
Kosumi K, Baba Y, Sakamoto A, Ishimoto T, Harada K, Nakamura K, Kurashige J, Hiyoshi Y, Iwatsuki M, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Oki E, Watanabe M, Hino S, Nakao M, Baba H.
Lysine-specific demethylase-1 contributes to malignant behavior by regulation of invasive activity and metabolic shift in esophageal cancer
Int J Cancer
2016
138(2):428-39
PubMed ID: 26240060
DOI: 10.1002/ijc.29714
|
|
12663
Song IH, Lee TS, Park YS, Lee JS, Lee BC, Moon BS, An GI, Lee HW, Kim KI, Lee YJ, Kang JH, Lim SM.
Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model
J Nucl Med
2016
57(7):1105-11
PubMed ID: 26917708
DOI: 10.2967/jnumed.115.167155
|
|
12969
Hamada J, Shoda K, Masuda K, Fujita Y, Naruto T, Kohmoto T, Miyakami Y, Watanabe M, Kudo Y, Fujiwara H, Ichikawa D, Otsuji E, Imoto I.
Tumor-promoting function and prognostic significance of the RNA-binding protein T-cell intracellular antigen-1 in esophageal squamous cell carcinoma
Oncotarget
2016
7(13):17111-28
PubMed ID: 26958940
DOI: 10.18632/oncotarget.7937
|
|
13992
Nakamura K, Baba Y, Kosumi K, Harada K, Shigaki H, Miyake K, Kiyozumi Y, Ohuchi M, Kurashige J, Ishimoto T, Iwatsuki M, Sakamoto Y, Yoshida N, Watanabe M, Nakao M, Baba H.
UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma
Oncotarget
2016
7(36):57821-5783
PubMed ID: 27507047
DOI: 10.18632/oncotarget.11067
|
|
13993
Pirayesh Islamian J, Mohammadi M, Baradaran B, Farajollahi A, Aghamiri SM, Asghari Jafarabadi M, Karami H, Monfaredan A, Shanehbandi D.
Enhancing radiosensitivity of TE1, TE8, and TE 11 esophageal squamous carcinoma cell lines by Hdm2-siRNA targeted gene therapy in vitro
Bioimpacts
2016
6(2):93-8
PubMed ID: 27525226
DOI: 10.15171/bi.2016.13
|
|
14119
Park M, Yoon HJ, Kang MC, Kwon J, Lee HW.
PTK7 regulates radioresistance through nuclear factor-kappa B in esophageal squamous cell carcinoma
Tumour Biol
2016
37(10):14217-14224
PubMed ID: 27557627
DOI: 10.1007/s13277-016-5288-3
|
|
7350
Nabeki B, Ishigami S, Uchikado Y, Sasaki K, Kita Y, Okumura H, Arigami T, Kijima Y, Kurahara H, Maemura K, Natsugoe S.
Interleukin-32 expression and Treg infiltration in esophageal squamous cell carcinoma.
Anticancer Res.
2015
35:2941-7
PubMed ID: 25964580
|
|
7382
Saito S, Morishima K, Ui T, Hoshino H, Matsubara D, Ishikawa S, Aburatani H, Fukayama M, Hosoya Y, Sata N, Lefor AK, Yasuda Y, Niki T.
The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma.
BMC Cancer
2015
15:82
PubMed ID: 25884729
DOI: 10.1186/s12885-015-1065-8
|
|
14284
Bill A, Gutierrez A, Kulkarni S, Kemp C, Bonenfant D, Voshol H, Duvvuri U, Gaither LA.
ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer
Oncotarget
2015
6(11):9173-88
PubMed ID: 25823819
DOI: 10.18632/oncotarget.3277
|
|
15151
Yokobori T, Bao P, Fukuchi M, Altan B, Ozawa D, Rokudai S, Bai T, Kumakura Y, Honjo H, Hara K, Sakai M, Sohda M, Miyazaki T, Ide M, Nishiyama M, Oyama T, Kuwano H.
Nuclear PROX1 is Associated with Hypoxia-Inducible Factor 1α Expression and Cancer Progression in Esophageal Squamous Cell Carcinoma
Ann Surg Oncol
2015
22 Suppl 3:S1566-73
PubMed ID: 26310281
DOI: 10.1245/s10434-015-4831-6
|
|
15184
Harada K, Baba Y, Ishimoto T, Kosumi K, Tokunaga R, Izumi D, Ohuchi M, Nakamura K, Kiyozumi Y, Kurashige J, Iwagami S, Miyamoto Y, Sakamoto Y, Yoshida N, Oki E, Watanabe M, Baba H.
Suppressor microRNA-145 Is Epigenetically Regulated by Promoter Hypermethylation in Esophageal Squamous Cell Carcinom
Anticancer Res
2015
35(9):4617-24
PubMed ID: 26254350
|
|
7847
Wang L, Xing J, Cheng R, Shao Y, Li P, Zhu S, Zhang S.
Abnormal Localization and Tumor Suppressor Function of Epithelial Tissue-Specific Transcription Factor ESE3 in Esophageal Squamous Cell Carcinoma
PLoS One
2015
10(5):e012
PubMed ID: 25950810
DOI: 10.1371/journal.pone.0126319
|
|
19049
Kwon J, Yoon HJ, Kim JH, Lee TS, Song IH, Lee HW, Kang MC, Park JH.
Cetuximab inhibits cisplatin-induced activation of EGFR signaling in esophageal squamous cell carcinoma
Oncol Rep
2014
32(3):1188-92
PubMed ID: 24993015
DOI: 10.3892/or.2014.3302
|
|
19524
Migita K, Sho M, Shimada K, Yasuda S, Yamato I, Takayama T, Matsumoto S, Wakatsuki K, Hotta K, Tanaka T, Ito M, Konishi N, Nakajima Y.
Significant involvement of herpesvirus entry mediator in human esophageal squamous cell carcinoma
Cancer
2014
120(6):808-17.
PubMed ID: 24249528
DOI: 10.1002/cncr.28491
|
|
13765
Sawayama H, Ishimoto T, Watanabe M, Yoshida N, Sugihara H, Kurashige J, Hirashima K, Iwatsuki M, Baba Y, Oki E, Morita M, Shiose Y, Baba H.
Small molecule agonists of PPAR-γ exert therapeutic effects in esophageal cancer
Cancer Res
2014
74(2):575-85
PubMed ID: 24272485
DOI: 10.1158/0008-5472.CAN-13-1836
|
|
15825
Inhibition of mitogen-activated protein kinase pathway can induce upregulation of human leukocyte antigen class I without PD-L1-upregulation in contrast to interferon-γ treatment
Inhibition of mitogen-activated protein kinase pathway can induce upregulation of human leukocyte antigen class I without PD-L1-upregulation in contrast to interferon-γ treatment
Cancer Sci
2014
105(10):1236-44
PubMed ID: 25154680
DOI: 10.1111/cas.12503
|
|
17132
Ichiro Akagi, Osamu Ishibashi, Takeshi Matsutani, Nobutoshi Hagiwara, Akihisa Matsuda, Tsutomu Nomura, Hiroshi Makino, Hiroshi Yoshida, Masao Miyashita, Eiji Uchida
Comprehensive Analysis of MicroRNA and mRNA Expression in Normal and Tumorous Human Esophageal Squamous Cell Lines Using Microarray Datasets
Dataset Papers in Science
2014
1-3:2014-12-15
DOI: 10.1155/2014/376541
|
|
17149
Yeo SY, Ha SY, Yu EJ, Lee KW, Kim JH, Kim SH.
ZNF282 (Zinc finger protein 282), a novel E2F1 co-activator, pr
Oncotarget
2014
5(23):12260-72
PubMed ID: 25373738
DOI: 10.18632/oncotarget.2630
|
|
16294
Britschgi A, Bill A, Brinkhaus H, Rothwell C, Clay I, Duss S, Rebhan M, Raman P, Guy CT, Wetzel K, George E, Popa MO, Lilley S, Choudhury H, Gosling M, Wang L, Fitzgerald S, Borawski J, Baffoe J, Labow M, Gaither LA, Bentires-Alj M.
Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling
Proc Natl Acad Sci U S A
2013
110(11):E1026-34
PubMed ID: 23431153
DOI: 10.1073/pnas.1217072110
|
|
18742
Sugimura K, Miyata H, Tanaka K, Hamano R, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Mori M, Doki Y.
Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma
Clin Cancer Res
2012
18(18):5144-53
PubMed ID: 22847808
DOI: 10.1158/1078-0432.CCR-12-0701
|
|
18266
Yamada A, Fujii S, Daiko H, Nishimura M, Chiba T, Ochiai A.
Aberrant expression of EZH2 is associated with a poor outcome and P53 alteration in squamous cell carcinoma of the esophagus
Int J Oncol
2011
38(2):345-53
PubMed ID: 21165554
DOI: 10.3892/ijo.2010.868
|
|
19034
Hamano R, Miyata H, Yamasaki M, Kurokawa Y, Hara J, Moon JH, Nakajima K, Takiguchi S, Fujiwara Y, Mori M, Doki Y.
Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway
Clin Cancer Res
2011
17(9):3029-38
PubMed ID: 21248297
DOI: 10.1158/1078-0432.CCR-10-2532
|
|
8430
Ooki A, Yamashita K, Kikuchi S, Sakuramoto S, Katada N, Watanabe M.
Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma.
Int. J. Cancer
2010
127:543-54
PubMed ID: 19960436
DOI: 10.1002/ijc.25082
|
|
18707
Rahadiani N, Ikeda J, Makino T, Tian T, Qiu Y, Mamat S, Wang Y, Doki Y, Aozasa K, Morii E.
Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma
Ann Surg Oncol
2010
17(5):1311-23
PubMed ID: 20066519
DOI: 10.1245/s10434-009-0895-5
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
DOI: 10.1111/j.1749-0774.2009.00071.x
|
Back
Top
CELL BANK Website